Jane Street Group LLC trimmed its stake in Arteris, Inc. (NASDAQ:AIP – Free Report) by 14.4% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 19,318 shares of the company’s stock after selling 3,261 shares during the quarter. Jane Street Group LLC’s holdings in Arteris were worth $149,000 at the end of the most recent quarter.
Several other institutional investors have also recently added to or reduced their stakes in the business. US Bancorp DE purchased a new position in Arteris during the third quarter worth about $34,000. The Manufacturers Life Insurance Company purchased a new position in Arteris during the second quarter worth about $86,000. Algert Global LLC purchased a new position in Arteris during the second quarter worth about $115,000. MetLife Investment Management LLC lifted its position in Arteris by 129.1% during the third quarter. MetLife Investment Management LLC now owns 16,951 shares of the company’s stock worth $131,000 after buying an additional 9,551 shares during the period. Finally, Dynamic Technology Lab Private Ltd purchased a new position in Arteris during the third quarter worth about $226,000. 64.36% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Separately, Rosenblatt Securities restated a “buy” rating and set a $15.00 price target on shares of Arteris in a research note on Wednesday, November 6th.
Insiders Place Their Bets
In other Arteris news, VP Paul L. Alpern sold 3,326 shares of Arteris stock in a transaction on Monday, January 6th. The stock was sold at an average price of $12.35, for a total transaction of $41,076.10. Following the sale, the vice president now owns 61,604 shares of the company’s stock, valued at $760,809.40. The trade was a 5.12 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Saiyed Atiq Raza sold 2,776 shares of Arteris stock in a transaction on Monday, January 6th. The shares were sold at an average price of $12.34, for a total value of $34,255.84. Following the sale, the director now directly owns 684,320 shares in the company, valued at $8,444,508.80. The trade was a 0.40 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 325,456 shares of company stock valued at $3,355,352 in the last quarter. Insiders own 33.70% of the company’s stock.
Arteris Price Performance
AIP stock opened at $11.22 on Tuesday. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.16 and a current ratio of 1.16. The stock has a 50-day simple moving average of $9.42 and a 200-day simple moving average of $8.22. Arteris, Inc. has a 1 year low of $4.83 and a 1 year high of $12.64. The firm has a market cap of $450.79 million, a P/E ratio of -11.69 and a beta of 1.17.
About Arteris
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
Featured Articles
- Five stocks we like better than Arteris
- 5 Top Rated Dividend Stocks to Consider
- 2 Stocks to Gain From Trump Universal Tariffs on Critical Imports
- What is Put Option Volume?
- Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Delta Can Fly to New Highs in 2025; Here’s Why
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.